Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Molecules (Basel, Switzerland)|June 21, 2020
Challenges in Chagas Disease Drug DevelopmentAmanda F Francisco, Shiromani Jayawardhana, Francisco Olmo, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2025
Intermittent suppressive posaconazole therapy is ineffective at mitigating cardiac and digestive tract pathologies in an experimental model of chronic Chagas diseaseShiromani Jayawardhana, Francisco Olmo, Amanda Fortes Francisco, et al.
Plos Pathogens|November 13, 2023
Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in miceShiromani Jayawardhana, Alexander I Ward, Amanda F Francisco, et al.
International Journal for Parasitology|January 15, 2011
Extraordinary Trypanosoma cruzi diversity within single mammalian reservoir hosts implies a mechanism of diversifying selectionMartin S Llewellyn, John B Rivett-Carnac, Sinead Fitzpatrick, et al.
Molecular Ecology|July 11, 2012
Contemporary cryptic sexuality in Trypanosoma cruziJuan David Ramírez, Felipe Guhl, Louisa A Messenger, et al.
Elife|May 10, 2022
Microevolution of Trypanosoma cruzi reveals hybridization and clonal mechanisms driving rapid genome diversificationGabriel Machado Matos, Michael D Lewis, Carlos Talavera-López, et al.
Scientific Reports|November 2, 2017
Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazoleMônica C Campos, Jody Phelan, Amanda F Francisco, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite InteractionsMartin C Taylor, Amanda F Francisco, Shiromani Jayawardhana, et al.
Pageof 8